Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Hca Healthcare, Inc. (HCA)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Hca Healthcare, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 860730.
Total stock buying since 2005: $164,238,084.
Total stock sales since 2005: $33,087,429,428.
Total stock option exercises since 2005: $364,257,937.
Table 3. Detailed insider trading at Hca Healthcare, Inc. (HCA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-05-13 | Foster Jon M (EVP and COO) | Sale | 15,698 | 369.32 | 5,797,663 |
| 2025-02-14 | Berres Jennifer (SVP & Chief Human Res. Officer) | Sale | 19,066 | 322.63 | 6,151,282 |
| 2025-02-07 | Berres Jennifer (SVP & Chief Human Res. Officer) | Option Ex | 11,780 | 120.11 | 1,414,895 |
| 2025-02-03 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 138 | .00 | 0 |
| 2024-11-14 | Akdamar Erol R (Group President) | Sale | 2,900 | 353.00 | 1,023,700 |
| 2024-11-14 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 1,474 | 357.99 | 527,677 |
| 2024-11-14 | Billington Phillip G (SVP-Internal Audit Services) | Sale | 3,897 | 350.00 | 1,363,950 |
| 2024-11-14 | Foster Jon M (EVP and COO) | Option Ex | 36,600 | 101.16 | 3,702,456 |
| 2024-11-12 | Akdamar Erol R (Group President) | Option Ex | 20,000 | 68.96 | 1,379,199 |
| 2024-11-12 | Billington Phillip G (SVP-Internal Audit Services) | Option Ex | 8,000 | 68.96 | 551,680 |
| 2024-11-11 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Option Ex | 4,710 | 173.12 | 815,395 |
| 2024-09-12 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 8,358 | 385.42 | 3,221,340 |
| 2024-09-10 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Option Ex | 22,080 | 145.24 | 3,206,899 |
| 2024-07-31 | Mcmanus Timothy M (Group President) | Option Ex | 7,500 | 77.13 | 578,475 |
| 2024-07-31 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 2,987 | 363.51 | 1,085,804 |
| 2024-07-29 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 1,864 | 359.92 | 670,890 |
| 2024-07-29 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Option Ex | 8,280 | 145.24 | 1,202,587 |
| 2024-07-29 | Reiner Deborah M (SVP - Mktg. & Communications) | Sale | 3,314 | 359.96 | 1,192,914 |
| 2024-07-29 | Wyatt Christopher F. (SVP & Controller) | Sale | 4,000 | 360.20 | 1,440,784 |
| 2024-07-25 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 1,857 | 355.05 | 659,327 |
| 2024-07-25 | Wyatt Christopher F. (SVP & Controller) | Option Ex | 9,300 | 101.16 | 940,788 |
| 2024-05-15 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 1,863 | 326.18 | 607,673 |
| 2024-05-15 | Foster Jon M (EVP and COO) | Option Ex | 39,465 | 75.77 | 2,990,263 |
| 2024-05-15 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Option Ex | 19,000 | 68.96 | 1,310,239 |
| 2024-05-09 | Cohen Jeffrey E. (SVP-Government Relations) | Sale | 1,650 | 313.00 | 516,450 |
| 2024-05-09 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 6,311 | 316.88 | 1,999,823 |
| 2024-05-07 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Option Ex | 18,660 | 139.06 | 2,594,859 |
| 2024-05-06 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 1,600 | 309.00 | 494,400 |
| 2024-05-03 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 890 | 312.00 | 277,680 |
| 2024-05-02 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 973 | 312.00 | 303,576 |
| 2024-03-20 | Wasserman Chad J (SVP and CIO) | Sale | 876 | 330.25 | 289,299 |
| 2024-03-18 | Wasserman Chad J (SVP and CIO) | Sale | 344 | 321.97 | 110,757 |
| 2024-03-18 | Wasserman Chad J (SVP and CIO) | Option Ex | 2,100 | 101.16 | 212,436 |
| 2024-02-09 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 4,262 | 306.21 | 1,305,075 |
| 2024-02-06 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Option Ex | 2,092 | 173.12 | 362,167 |
| 2024-02-06 | Rutherford Bill B (CFO and EVP) | Sale | 6,000 | 310.63 | 1,863,780 |
| 2024-02-05 | Mosier Sammie S (SVP & Chief Nurse Executive) | Sale | 1,645 | 312.00 | 513,240 |
| 2024-02-05 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Option Ex | 8,550 | 84.23 | 720,192 |
| 2024-02-05 | Wyatt Christopher F. (SVP & Controller) | Sale | 4,000 | 312.42 | 1,249,680 |
| 2024-02-03 | Wasserman Chad J (SVP and CIO) | Option Ex | 127 | .00 | 0 |
| 2024-02-03 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 137 | .00 | 0 |
| 2024-02-02 | Wasserman Chad J (SVP and CIO) | Sale | 652 | 312.04 | 203,450 |
| 2024-02-02 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 6,298 | 226.21 | 1,424,670 |
| 2024-02-02 | Rutherford Bill B (CFO and EVP) | Option Ex | 19,100 | 69.58 | 1,328,978 |
| 2024-02-01 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Option Ex | 12,994 | 202.07 | 2,625,671 |
| 2024-01-31 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 3,861 | 307.00 | 1,185,327 |
| 2024-01-31 | Wyatt Christopher F. (SVP & Controller) | Option Ex | 11,680 | 91.56 | 1,069,420 |
| 2024-01-31 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 3,200 | 306.79 | 981,734 |
| 2024-01-29 | Hammett Richard A (Group President) | Option Ex | 600 | .00 | 0 |
| 2024-01-29 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 323 | .00 | 0 |
| 2024-01-28 | Mcalevey Michael R (SVP & Chief Legal Officer) | Option Ex | 1,940 | .00 | 0 |
| 2023-11-13 | Akdamar Erol R (Group President) | Option Ex | 26,825 | 47.97 | 1,286,795 |
| 2023-08-14 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 5,204 | 269.12 | 1,400,516 |
| 2023-08-11 | Cohen Jeffrey E. (SVP-Government Relations) | Sale | 1,500 | 270.00 | 405,000 |
| 2023-08-03 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 2,916 | 270.00 | 787,320 |
| 2023-04-28 | Akdamar Erol R (Group President) | Sale | 3,500 | 285.00 | 997,500 |
| 2023-04-28 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Option Ex | 8,844 | 142.15 | 1,257,174 |
| 2023-04-28 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 12,556 | 284.44 | 3,571,390 |
| 2023-04-24 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 4,473 | 288.38 | 1,289,914 |
| 2023-04-24 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Option Ex | 32,020 | 101.16 | 3,239,143 |
| 2023-04-14 | Paslick P. Martin (SVP and CIO) | Sale | 2,687 | 275.00 | 738,925 |
| 2023-04-12 | Paslick P. Martin (SVP and CIO) | Option Ex | 6,340 | 81.96 | 519,626 |
| 2023-04-10 | Paslick P. Martin (SVP and CIO) | Sale | 2,539 | 270.00 | 685,530 |
| 2023-04-05 | Paslick P. Martin (SVP and CIO) | Option Ex | 6,000 | 81.96 | 491,759 |
| 2023-04-04 | Paslick P. Martin (SVP and CIO) | Sale | 3,034 | 265.00 | 804,010 |
| 2023-02-17 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 1,734 | 263.61 | 457,096 |
| 2023-02-16 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Option Ex | 4,575 | 101.16 | 462,807 |
| 2023-02-07 | Berres Jennifer (SVP & Chief Human Res. Officer) | Sale | 4,000 | 255.23 | 1,020,912 |
| 2023-02-03 | Akdamar Erol R (Group President) | Option Ex | 9,000 | 45.30 | 407,700 |
| 2023-02-03 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 138 | .00 | 0 |
| 2023-02-03 | Reiner Deborah M (SVP - Mktg. & Communications) | Sale | 7,941 | 257.61 | 2,045,696 |
| 2023-02-03 | Rutherford Bill B (CFO and EVP) | Sale | 30,000 | 258.19 | 7,745,579 |
| 2023-02-03 | Hazen Samuel N (CEO) | Option Ex | 59,000 | 68.96 | 4,068,639 |
| 2023-02-02 | Akdamar Erol R (Group President) | Sale | 3,000 | 258.63 | 775,890 |
| 2023-02-01 | Wyatt Christopher F. (SVP & Controller) | Sale | 4,900 | 253.30 | 1,241,170 |
| 2023-02-01 | Cuffe Michael S. (EVP and Chief Clinical Officer) | Sale | 4,000 | 257.11 | 1,028,440 |
| 2023-02-01 | Paslick P. Martin (SVP and CIO) | Sale | 1,000 | 256.95 | 256,949 |
| 2023-02-01 | Foster Jon M (EVP and COO) | Sale | 16,424 | 251.98 | 4,138,486 |
| 2023-02-01 | Rutherford Bill B (CFO and EVP) | Option Ex | 64,000 | 69.27 | 4,433,280 |
| 2023-01-31 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Option Ex | 1,250 | 69.58 | 86,975 |
| 2023-01-30 | Hammett Richard A (Group President) | Option Ex | 598 | .00 | 0 |
| 2023-01-30 | Mcmanus Timothy M (Group President) | Sale | 7,900 | 254.33 | 2,009,175 |
| 2023-01-30 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 273 | .00 | 0 |
| 2023-01-30 | Wyatt Christopher F. (SVP & Controller) | Option Ex | 12,000 | 81.96 | 983,519 |
| 2023-01-30 | Foster Jon M (EVP and COO) | Option Ex | 35,955 | 69.27 | 2,490,602 |
| 2023-01-29 | Hammett Richard A (Group President) | Option Ex | 600 | .00 | 0 |
| 2023-01-29 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 322 | .00 | 0 |
| 2023-01-28 | Mcalevey Michael R (SVP & Chief Legal Officer) | Option Ex | 1,940 | .00 | 0 |
| 2023-01-23 | Paslick P. Martin (SVP and CIO) | Option Ex | 6,000 | 81.96 | 491,759 |
| 2022-10-28 | Billington Phillip G (SVP-Internal Audit Services) | Sale | 8,332 | 222.58 | 1,854,519 |
| 2022-10-28 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Sale | 12,946 | 223.18 | 2,889,301 |
| 2022-10-28 | Hall Charles J (Group President) | Sale | 9,838 | 223.50 | 2,198,793 |
| 2022-10-28 | Hall Charles J (Group President) | Option Ex | 31,147 | 120.11 | 3,741,066 |
| 2022-10-27 | Moore A Bruce Jr (Group President - Service Line) | Option Ex | 35,625 | 37.18 | 1,324,537 |
| 2022-10-26 | Billington Phillip G (SVP-Internal Audit Services) | Option Ex | 16,575 | 37.18 | 616,258 |
| 2022-10-25 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Option Ex | 27,500 | 47.97 | 1,319,175 |
| 2022-07-25 | Elcan Patricia F (10% Owner) | Buy | 325 | 198.66 | 64,564 |
| 2022-05-13 | Berres Jennifer (SVP & Chief Human Res. Officer) | Sale | 2,358 | 218.87 | 516,086 |
| 2022-05-03 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 500 | 215.38 | 107,690 |
| 2022-05-02 | Frist Thomas F Jr (10% Owner) | Buy | 89,100 | 212.48 | 18,932,324 |
| 2022-04-29 | Mcalevey Michael R (SVP & Chief Legal Officer) | Buy | 1,110 | 218.56 | 242,601 |
| 2022-04-28 | Smith Andrea B (Director) | Buy | 1,160 | 213.63 | 247,815 |
| 2022-03-11 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Sale | 11,522 | 269.00 | 3,099,418 |
| 2022-02-18 | Hazen Samuel N (CEO) | Option Ex | 6,011 | .00 | 0 |
| 2022-02-17 | Moore A Bruce Jr (Group President - Service Line) | Sale | 9,367 | 253.18 | 2,371,499 |
| 2022-02-16 | Moore A Bruce Jr (Group President - Service Line) | Sale | 20,633 | 244.01 | 5,034,678 |
| 2022-02-03 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 137 | .00 | 0 |
| 2022-01-31 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 273 | .00 | 0 |
| 2022-01-30 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 272 | .00 | 0 |
| 2022-01-29 | Mosier Sammie S (SVP & Chief Nurse Executive) | Option Ex | 323 | .00 | 0 |
| 2022-01-05 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Option Ex | 23,375 | 47.97 | 1,121,298 |
| 2022-01-04 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Sale | 22,198 | 259.23 | 5,754,387 |
| 2021-12-29 | Sowell Joseph A Iii (SVP; Chief Development Officer) | Option Ex | 42,750 | 37.18 | 1,589,445 |
| 2021-11-11 | Foster Jon M (Group President) | Sale | 16,294 | 242.05 | 3,943,995 |
| 2021-11-10 | Billington Phillip G (SVP-Internal Audit Services) | Sale | 8,252 | 246.25 | 2,032,096 |
| 2021-11-10 | Reiner Deborah M (SVP - Mktg. & Communications) | Sale | 2,052 | 246.23 | 505,261 |
| 2021-11-09 | Englebright Jane D. (SVP and Chief Nursing Officer) | Sale | 3,364 | 249.61 | 839,688 |
| 2021-11-09 | Foster Jon M (Group President) | Option Ex | 33,375 | 47.97 | 1,600,998 |
| 2021-11-08 | Billington Phillip G (SVP-Internal Audit Services) | Option Ex | 15,000 | 22.95 | 344,250 |
| 2021-11-08 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Option Ex | 8,095 | 142.15 | 1,150,704 |
| 2021-11-05 | Berres Jennifer (SVP & Chief Human Res. Officer) | Option Ex | 10,640 | 75.77 | 806,192 |
| 2021-11-05 | Wyatt Christopher F. (SVP & Controller) | Sale | 2,100 | 252.94 | 531,174 |
| 2021-11-04 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 3,815 | 250.48 | 955,596 |
| 2021-11-04 | Rutherford Bill B (CFO and EVP) | Sale | 20,647 | 250.00 | 5,161,750 |
| 2021-11-03 | Englebright Jane D. (SVP and Chief Nursing Officer) | Option Ex | 7,688 | 69.58 | 534,931 |
| 2021-11-03 | Rutherford Bill B (CFO and EVP) | Sale | 9,353 | 250.00 | 2,338,250 |
| 2021-11-02 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Option Ex | 8,325 | 58.47 | 486,721 |
| 2021-11-02 | Hazen Samuel N (CEO) | Sale | 50,000 | 251.75 | 12,587,400 |
| 2021-10-29 | Wyatt Christopher F. (SVP & Controller) | Option Ex | 5,260 | 79.80 | 419,748 |
| 2021-10-29 | Rutherford Bill B (CFO and EVP) | Option Ex | 78,625 | 47.97 | 3,771,641 |
| 2021-10-29 | Hazen Samuel N (CEO) | Option Ex | 152,625 | 47.97 | 7,321,421 |
| 2021-08-05 | Englebright Jane D. (SVP and Chief Nursing Officer) | Sale | 4,018 | 250.12 | 1,004,998 |
| 2021-08-03 | Cuffe Michael S. (President-Physician Services) | Sale | 2,500 | 251.91 | 629,775 |
| 2021-08-03 | Hall Charles J (Group President) | Sale | 6,000 | 252.94 | 1,517,640 |
| 2021-08-03 | Moore A Bruce Jr (Group President - Service Line) | Option Ex | 37,500 | 37.18 | 1,394,250 |
| 2021-08-02 | Englebright Jane D. (SVP and Chief Nursing Officer) | Sale | 409 | 249.57 | 102,073 |
| 2021-08-02 | Hall Charles J (Group President) | Sale | 3,000 | 250.94 | 752,820 |
| 2021-08-02 | Perlin Jonathan B (Pres-Clinical Operations & CMO) | Sale | 40,000 | 250.02 | 10,000,640 |
| 2021-07-30 | Englebright Jane D. (SVP and Chief Nursing Officer) | Sale | 2,900 | 249.43 | 723,352 |
| 2021-07-29 | Englebright Jane D. (SVP and Chief Nursing Officer) | Sale | 200 | 249.36 | 49,872 |
| 2021-07-27 | Englebright Jane D. (SVP and Chief Nursing Officer) | Option Ex | 8,800 | 58.47 | 514,492 |
| 2021-07-27 | Paslick P. Martin (SVP and CIO) | Sale | 7,466 | 250.00 | 1,866,500 |
| 2021-07-27 | Hall Charles J (Group President) | Sale | 3,000 | 249.94 | 749,820 |
| 2021-07-22 | Whalen Kathleen M (SVP & Chief Ethics Officer) | Sale | 886 | 246.90 | 218,751 |
| 2021-07-21 | Torres Kathryn A. (SVP-Payer Contracting & Align.) | Sale | 1,000 | 252.00 | 252,000 |
| 2021-07-21 | Paslick P. Martin (SVP and CIO) | Option Ex | 17,080 | 69.58 | 1,188,426 |
| 2021-05-11 | Reiner Deborah M (SVP - Mktg. & Communications) | Sale | 3,432 | 208.33 | 714,988 |
| 2021-05-06 | Paslick P. Martin (SVP and CIO) | Sale | 7,672 | 207.55 | 1,592,323 |
| 2021-05-04 | Wyatt Christopher F. (SVP & Controller) | Sale | 4,604 | 204.00 | 939,216 |
| 2021-05-04 | Paslick P. Martin (SVP and CIO) | Option Ex | 19,000 | 68.96 | 1,310,239 |
Insider trading activities including stock purchases, stock sales, and option exercises
of HCA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Hca Healthcare, Inc. (symbol HCA,
CIK number 860730) see
the Securities and Exchange Commission (SEC) website.